BamSEC and AlphaSense Join Forces
Learn More

Cellectar Biosciences Inc.

NASDAQ: CLRB    
Share price (6/6/25): $0.36    
Market cap (6/6/25): $16.6 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 5 pages Holder of Common Stock Purchase Warrants Issued on June 5, 2020, October 25, 2022 and July 21, 2024 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 8 pages [Name] [Address] Re: Reprice and Reload Offer of Common Stock Purchase Warrants to Whom It May Concern
12/34/56
EX-10.1
from 8-K 11 pages Cellectar Biosciences, Inc. 2021 Stock Incentive Plan, as Amended
12/34/56
EX-10.1
from 8-K 64 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 11 pages Appendix a Cellectar Biosciences, Inc. 2021 Stock Incentive Plan, as Amended
12/34/56
EX-10.26
from 10-K 11 pages Material contract
12/34/56
EX-10.1
from 8-K 13 pages Director and Officer Indemnification Agreement
12/34/56
EX-10.3
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 41 pages Private Placement Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 1 to Cellectar Biosciences, Inc. 2021 Stock Incentive Plan
12/34/56
EX-10.1
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 11 pages Cellectar Biosciences, Inc. 2021 Stock Incentive Plan
12/34/56
EX-10.2
from 8-K 29 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 42 pages Cellectar Biosciences, Inc. $14,500,000 Common Stock Equity Distribution Agreement
12/34/56
EX-10.1
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 12 pages Cellectar Biosciences, Inc. Amended and Restated 2015 Stock Incentive Plan
12/34/56
EX-10.37
from 10-K 3 pages Cellectar Biosciences, Inc. 2015 Stock Incentive Plan Non-Statutory Stock Option Agreement
12/34/56
EX-10.36
from 10-K 3 pages Non-Statutory Stock Option Granted by Cellectar Biosciences, Inc.(the “Company”) Under the 2015 Stock Incentive Plan
12/34/56